A panel of precision medicine experts from children’s hospitals take part in a conversation that highlights the work being done to improve the way rare diseases and pediatric cancer is diagnosed and treated.
Moderator: Samuel Blackman, MD, PhD, Co-Founder and Chief Medical Officer, Day One Biopharmaceuticals
- Josh Bonkowsky, MD, PhD, Medical Director of the Primary Children’s Center for Personalized Medicine, Intermountain Healthcare
- Tomi Pastinen, MD, PhD, Director, Genomic Medicine Center, Children’s Mercy Kansas City
- Peter White, PhD, Senior Director of The Steve & Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children’s Hospital